← Leaderboards
Abraham Chachoua
New York University School Of Medicine
$21,006
Attributed
$21,006
Total exposure
2
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$21,006 · 2
By mechanism
M01$21,006 · 2
Top collaborators
No co-investigators on record.
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Franco M Muggia$5,360,861
- Howard S Hochster$9,390,994
- Maarten C Bosland$10,491,195
- Harvey Ira Pass$7,723,189
- Jay Cooper$168,048
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectNeoplasm /Cancer ChemotherapyClinical ResearchHuman Therapy EvaluationProstate Specific AntigenGrowth Factor ReceptorsIsoxazolesMalePlatelet Derived Growth FactorProstate NeoplasmsBiopsyMesotheliomaDrug Screening /EvaluationDrug Administration RoutesCis Platinum CompoundLiposomesPleural Neoplasms
Grant awards (6)
SU101 IN PATIENTS W/ PSA+ PROSTATE CANCER(101 008)$0
M01 · FY2002 · RR
SU101 IN PATIENTS W/ PSA+ PROSTATE CANCER(101 008)$0
M01 · FY2001 · RR
SU101 IN PATIENTS W/ PSA+ PROSTATE CANCER(101 008)$21,006
M01 · FY2000 · RR
SU101 IN PATIENTS W/ PSA+ PROSTATE CANCER(101 008)$0
M01 · FY2000 · RR
CISPLATIN ANALOG IN MALIGNANT PLEURAL MESOTHELIOMA$0
M01 · FY2000 · RR
CISPLATIN ANALOG IN MALIGNANT PLEURAL MESOTHELIOMA$0
M01 · FY2000 · RR